Cargando…
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has overwhelmed the health systems worldwide. Data regarding the impact of COVID-19 on cancer patients (CPs) undergoing or candidate for immune checkpoint inhibitors (ICIs) are lacking. We depicted the practice and adaptations in the manag...
Ejemplares similares
-
The unusual first sign of presentation of renal cell carcinoma: a rare case report
por: Morra, Rocco, et al.
Publicado: (2022) -
The European Reference Network: the keystone for the management of rare thoracic cancers
por: Morra, Rocco, et al.
Publicado: (2022) -
Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemic
por: Pietroluongo, Erica, et al.
Publicado: (2022) -
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?
por: Montella, Liliana, et al.
Publicado: (2022) -
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response
por: Cernera, Gustavo, et al.
Publicado: (2023)